| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 88741 |
68Ga-L-NETA-四嗪(Tz)分子探针 |
171 |
WYQ |
2024-12-03 |
| 88742 |
3-(3,5-二甲基吡唑基)-6-肼基-1,2,4,5-四嗪(DAHTz)与3,5-二硝基水杨酸盐(DNSA)的结合体(DAHTz·DNSA·H2O) |
208 |
WYQ |
2024-12-03 |
| 88743 |
3,6-二(2H-5-四唑基)-1,2,4,5-四嗪(BTT) |
273 |
WYQ |
2024-12-03 |
| 88744 |
1,1′-二甲基-5,5′-偶氮四嗪(DMATZ) |
124 |
WYQ |
2024-12-03 |
| 88745 |
稀土纳米颗粒NaGdF4修饰四嗪(NaGdF4-Tz) |
256 |
WYQ |
2024-12-03 |
| 88746 |
alkynyl-FA,炔基修饰叶酸 |
157 |
wyh |
2024-12-03 |
| 88747 |
6-(3,5-二甲基吡唑)-N-(1H-1,2,4-三唑)-1,2,4,5-四嗪-3-氨(DPTTz) |
187 |
WYQ |
2024-12-03 |
| 88748 |
6-(1H-吡唑)-N-(1H-1,2,4-三唑)-1,2,4,5-四嗪-3-氨(PTTz) |
180 |
WYQ |
2024-12-03 |
| 88749 |
白蛋白靶向的布洛芬-Gd-DOTA,Ibu-Gd-BSA NPs |
159 |
wyh |
2024-12-03 |
| 88750 |
Cy5.5-NKL,Cy5.5标记NKL新型探针 |
140 |
wyh |
2024-12-03 |
| 88751 |
DOTA修饰司帕沙星 , DOTA-SPFX |
174 |
wyh |
2024-12-03 |
| 88752 |
DOTA-PEG-GA, DOTA-聚乙二醇-GA |
130 |
wyh |
2024-12-03 |
| 88753 |
3,6-双(3,5-二甲基吡唑)-1,2,4,5-四嗪(BT) |
130 |
WYQ |
2024-12-03 |
| 88754 |
钆(Gd)金属配合物(Gd-DOTA) |
259 |
wyh |
2024-12-03 |
| 88755 |
3,6-双硝基胍基-1,2,4,5-四嗪双氨基胍盐(AG2DNGTz) |
139 |
WYQ |
2024-12-03 |
| 88756 |
3-(3,5-二甲基吡唑基)-6-苯基亚甲基腙-1,2,4,5-四嗪(DAHBTz) |
120 |
WYQ |
2024-12-03 |
| 88757 |
DOTA-Cy5.5-PS,DOTA-Cy5.5-聚苯乙烯 |
159 |
wyh |
2024-12-03 |
| 88758 |
3-(3,5-二甲基吡唑基)-6-肼基-1,2,4,5-四嗪(DAHTz) |
119 |
WYQ |
2024-12-03 |
| 88759 |
NH2-PEG-DOTA-PEG-NH2,氨基-聚乙二醇-DOTA-聚乙二醇-氨基 |
164 |
wyh |
2024-12-03 |
| 88760 |
P(VDF-TrFE)@DOTA-Gd@RGD ,复合压电纳米粒子 |
171 |
wyh |
2024-12-03 |
| 88761 |
双吡啶基配体3,6-二(4-吡啶基)-1,2,4,5-四嗪(DPT) |
194 |
WYQ |
2024-12-03 |
| 88762 |
四嗪-聚乙二醇-N-羟基琥珀酰亚胺酯偶联1,2-二硬脂酰基-sn-甘油基-3-磷酸乙醇胺-N-[氨基(聚乙二醇)-2000](DSPE-PEG2k-NH2) |
140 |
WYQ |
2024-12-03 |
| 88763 |
修饰Tetrazine的脂质分子(DSPE-PEG2k-PEG5-Tetrazine) |
159 |
WYQ |
2024-12-03 |
| 88764 |
3,6-双硝基胍基-1,2,4,5-四嗪双胍盐(G2DNGTz) |
156 |
WYQ |
2024-12-03 |
| 88765 |
3,6-双(3-硝基-1,2,4-噁二唑-5-胍基)-1,2,4,5-四嗪(NOG2Tz) |
183 |
WYQ |
2024-12-03 |
| 88766 |
(68)Ga-NOTA-Tz)结合了放射性同位素^(68)Ga |
151 |
WYQ |
2024-12-03 |
| 88767 |
HPMADOTAGd,DOTA偶联多聚HPMAGd磁共振成像探针 |
157 |
wyh |
2024-12-03 |
| 88768 |
1,2,3,4-四嗪-1,3-二氧化物(Benzo-1,2,3,4-tetrazine-1,3-dioxide) |
211 |
WYQ |
2024-12-03 |
| 88769 |
DOTAtEBTMTP1,DOTA修饰tEBTMTP1化合物 |
144 |
wyh |
2024-12-03 |
| 88770 |
3,6二氨基-1,2,4,5-四嗪-1,4-二氧化物(DATZO2) |
158 |
WYQ |
2024-12-03 |
| 88771 |
DOTA-VEGFDEE ,DOTA偶联突变体VEGFDEE |
156 |
wyh |
2024-12-03 |
| 88772 |
3,6-双(3,5-二甲基-吡唑-1-酰基)-1,2,4-四嗪(BT) |
143 |
WYQ |
2024-12-03 |
| 88773 |
DOTA-Cy5.5-NP,聚合物修饰上双功能螯合剂DOTA和近红外染料Cy5.5 |
143 |
wyh |
2024-12-03 |
| 88774 |
1,2,3,4-四嗪-1,3-二氧化物;Benzo-1,2,3,4-tetrazine-1,3-dioxide |
168 |
WYQ |
2024-12-03 |
| 88775 |
DOTA-dPEG2-R954,DOTA偶联R954衍生物 |
153 |
wyh |
2024-12-03 |
| 88776 |
3,6二氨基-1,2,4,5-四嗪-1,4-二氧化物(DATZO2);3,6-Diamino-1,2,4,5-tetrazine-1,4-dioxide |
145 |
WYQ |
2024-12-03 |
| 88777 |
3,6-双(3,5-二甲基-吡唑-1-酰基)-1,2,4-四嗪(BT);3,6-bis ( 3,5-dimethyl-pyrazol-1-oyl)-1,2,4,5-tetrazine |
153 |
WYQ |
2024-12-03 |
| 88778 |
3,6-双胍基-1,2,4,5-四嗪(DGTZ) |
202 |
WYQ |
2024-12-03 |
| 88779 |
氨基酸衍生物L-4-四嗪-苯丙氨酸 |
175 |
WYQ |
2024-12-03 |
| 88780 |
3,6-双(1-氢-1,2,3,4-四唑-5-氨基)-1,2,4,5-四嗪(BTATz) |
171 |
WYQ |
2024-12-03 |
| 88781 |
3-氨基-6-(3,5-二甲基吡唑基-1-基)-1,2,4-三唑[4,3-b]-1,2,4,5-四嗪(ADTTz) |
146 |
WYQ |
2024-12-03 |
| 88782 |
3-[(对甲氧基苯基)亚甲基腙]-6-(3,5-二甲基吡唑)-1,2,4,5-四嗪(DPMHT) |
167 |
WYQ |
2024-12-03 |
| 88783 |
3-[(3-甲氧基-4-羟基苯基)亚甲基腙]-6-(3,5-二甲基吡唑)-1,2,4,5-四嗪(DMPT) |
323 |
WYQ |
2024-12-03 |
| 88784 |
[Tc-99m]HYNIC-PEG(11)-Tz;[Tc-99m]标记联肼尼克酰胺多肽--PEG11-四嗪 |
153 |
WYQ |
2024-12-03 |
| 88785 |
maleimide-PEG-NHS ,马来酰亚胺-聚乙二醇-活性酯 |
153 |
wyh |
2024-12-03 |